{"podcast":{"title":"Cell & Gene: The Podcast","slug":"cell-gene-the-podcast-4048431","podcast_index_feed_id":4048431,"rss_url":"https://rss.buzzsprout.com/1810482.rss","website_url":"https://www.buzzsprout.com/1810482","image_url":"https://storage.buzzsprout.com/f3p8rfd9kizh4zywm5msg5goq7nu?.jpg","author":"Erin Harris","episode_count":140,"summary":"Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.","last_synced_at":"2026-06-18T18:19:19.741610+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431"},"episode":{"title":"Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness","slug":"inside-a-breakthrough-her2-immunotherapy-for-pmo-with-os-therapies-paul-romness","published_at":"2026-02-12T11:00:00+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/inside-a-breakthrough-her2-immunotherapy-for-pmo-with-os-therapies-paul-romness","show_page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431","url":"https://www.buzzsprout.com/1810482/episodes/18655119-inside-a-breakthrough-her2-immunotherapy-for-pmo-with-os-therapies-paul-romness.mp3","audio_url":"https://www.buzzsprout.com/1810482/episodes/18655119-inside-a-breakthrough-her2-immunotherapy-for-pmo-with-os-therapies-paul-romness.mp3","summary":"We love to hear from our listeners. Send us a message. In episode 122 of Cell & Gene: The Podcast, Host Erin Harris talks to Paul Romness, CEO of OS Therapies, to learn the company’s mission to address the severe unmet need in pulmonary metastatic osteosarcoma (PMO), a rare pediatric cancer with no established standard of care once it metastasizes. Romness explains how OS Therapies’ off-the-shelf HER2-targeted immunotherapy aims to significantly improve outcomes by stimulating a robust im...","meta_description":"We love to hear from our listeners. Send us a message. In episode 122 of Cell & Gene: The Podcast, Host Erin Harris talks to Paul Romness, CEO of OS T…","key_points":[],"chapters":[],"topics":[],"duration_seconds":860,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/inside-a-breakthrough-her2-immunotherapy-for-pmo-with-os-therapies-paul-romness/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/inside-a-breakthrough-her2-immunotherapy-for-pmo-with-os-therapies-paul-romness.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}